There is optimism in Mission’s work in neurodegenerative conditions, in particular, because DUBs play an important role in keeping a cell healthy by regulating the degradation of the misfolded, toxic proteins that are believed to cause impaired function and death of nerve cells in the brain.

The company  signed a collaboration in this area with US drugmaker AbbVie in November, 2018.